EphemerisXResearch

Complete Response Letters

Grace Therapeutics U.S., Inc.: nimodipine

What FDA's Complete Response Letters to the company say, in the letters' own words.

Complete Response Letter, Apr 23, 2026

The facility should provide satisfactory responses to these deficiencies to the FDA office indicated on the FDA Form 483 prior to your complete response.
Complete Response Letter · Apr 23, 2026 · p. 3Open the letter at p. 3 ↗CRL_NDA220304_20260423:p1:s25

More Complete Response Letters

All companies in the CRL Tracker →

Updated Sep 30, 2026 · built from 283 companies in the EphemerisX knowledge graph. This page is regenerated as companies are added.